Thyroide Eye Disease
-
Upload
po-lindara -
Category
Health & Medicine
-
view
201 -
download
1
description
Transcript of Thyroide Eye Disease
![Page 1: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/1.jpg)
Thyroid Eye Disease
Ea RaksmeyPo Lindara
![Page 2: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/2.jpg)
Outline
• Introduction to TED• Epidemiology• Pathogenesis • Clinical features
– Systemic – Ocular
– Diagnosis– Prognosis– Management:
– Supporting care– Medical– Surgical
![Page 3: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/3.jpg)
Introduction• TED or Graves ophthalmopathy • Auto-immune • Excessive secretion of thyroid hormones • Mostly associated with:
– Graves hyperthyroidism – Hashimoto thyroiditis– Euthyroidism
• Characteristics – Lid retraction – Lid lag– Proptosis– Restcrictive extraocular myopathy – ON compressoin
![Page 4: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/4.jpg)
Epidemiology
• Female 4x• Smokers 7x• 3rd-4th decade of life • Associated with:
– 90% Graves hyperthyroidism – 6% Euthyroidism – 3% Hashimoto thyroiditis – 1% Primary hypothyroidism
• Onset: – 20% of TED is diagnosed same time as hyperthyroidism – 60% of eye disease occur 1 year after thyroid disease – Only 30% of hyperthyroidism TED
![Page 5: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/5.jpg)
Pathogenesis
Fibroblast
Adipogenesis Fat HypertrophySynthesis of GAG
Inflammatory reaction
IgGTSH-R mRNA synthesis
T-Cells Stimulation
![Page 6: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/6.jpg)
Systemic Features
![Page 7: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/7.jpg)
Ocular Features• Symptoms:
– Grittiness – Photophobia – Lacrimation – Retrobulbar discomfort
• Signs: – Lid retraction – Lid lag– Restrictive EOM movement– Proptosis– ON compression
• 2 Stages: – Congestive: remits within 3 years, 10% long term problems– Fibrotic: restrictive movement
![Page 8: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/8.jpg)
Lid Retraction• 50%• Fibrotic contracture of levator:
– Worse in downgaze
• Secondary overreaction of levator-SR complex:– Secondary hypotrophia caused by fibrosis of IR– Worse in upgaze
• Humorally induced overreaction of Müller muscle:– Sympathetic stimulation by thyroid hormones
• 3 signs:
Dalrymple Sign Kocher Sign Von Graefe Sign
![Page 9: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/9.jpg)
Proptosis
• Axial • Uni/bilateral • Symmetrical/asymmetrical • Inflammatory cells infiltration GAG fluid retention
increase orbital pressure proptosis
![Page 10: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/10.jpg)
Restrictive EOM
• 30-50%• Inflammation of EOM
– cells infiltration retain fluid swelling compression– Muscle fibers degeneration fibrosis
• Elevation defect: IR fibrosis• Abduction defect: MR fibrosis• Depression defect: SR fibrosis• Adduction: LR fibrosis
![Page 11: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/11.jpg)
ON Compression • Uncommon but serious • Inflammation of EOM cells infiltration GAG fluid
retention orbital pressure compression • +/- proptosis • Signs:
– Reduced VA +/- RAPD, color desaturation– VF defect: central or paracentral, increased IOP (confused with POAG)– OD is normal, might swollen and rarely atrophic
Enlargement of recti with tendon sparing
![Page 12: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/12.jpg)
Diagnosis• 2 of 3 sign present
– Thyroid dysfunction:• Grave• Hashimoto• Thyroid Ab, TSH-R, TBII, TSI, antimicrosomal
– Orbital sign as above– Rx evidencen of uni/bilateral fusiform
enlargement of 1 or more• MR• IR• SR/ elevator complex
• If only 1 orbital sign; observe
![Page 13: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/13.jpg)
Differential diagnosis
• VEIIN +Miscellous:– Vascular– Endocrine– Infection– Inflammation– Neoplastic– Miscellous
![Page 14: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/14.jpg)
Prognosis– self-limiting disease average lasts 1 year– 2-3 years in smoker, 7 x develop the orbital– Reactivation 5-10%– Poor prognosis feature include:
• smoking• rapidly progressive orbitopathy• dermopathy
– Most patient require only support care– Intervention may be necessary if inflammation
is severe– long-term F/U:
• Visual loss from ON is uncommon• >50% thought that their looked abnormal• 38% were dissatisfied
![Page 15: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/15.jpg)
Management
![Page 16: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/16.jpg)
Treatement
• Supportive care:– Stop smoking– Lubricant (methylcellulose)– cool compress– head elevated– fluid diet– Prism lens– Botulinum toxin Mϋller muscle– 5% guanthidine (worse by side effect)
![Page 17: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/17.jpg)
Medication• Corticosteroid:
– to suppress immune properties– Indication (active inflammation) :
• Erythema• Eyelid edema• Compressive Opticneuropathy
– starting:• 60-100mg orally• short-term pulse IV; 1g daily 1 week to 2
months• retrobulbar or peribulbar 20mg /0,5cc
triamcinolone weekly for 4 weeks(benificial on diplopia and EOM size without significan s.e.)
![Page 18: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/18.jpg)
Medication• Cyclosporin :
– compare to steroid (21% vs 61%)– very limited role– s.e. nephrotoxicity, hypertension
• Methothrexate:– second-line treatment with recalcitrant TED
to control the clinical profile and delay surgery untill the disease stability
• Ticlonidine, IV immune globulin• Somatostatin analogue
![Page 19: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/19.jpg)
Radiation therapy
– Mechanism effect is unclear– induce terminal differentiation of
fibroblast– kill tissue-bound monocyte– clinical trial design show no statistically
significant compared with the natural history of the diseas
– Should avoid with: diabetes, vasculitis, may exacerbate retinopathy.
![Page 20: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/20.jpg)
Surgery
• Orbital decompression• Strabismus surgery• Eyelid retraction repair
![Page 21: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/21.jpg)
Orbital decompression
• to create more space for the swollen tissue by expanding the wall of the orbit
• Indication:– CON– excessive proptosis :
• Globe subluxation• Cornea ulcer• Steroid depending• Intractable pain• Cosmetic
![Page 22: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/22.jpg)
Strabismus surgery
• stable at least 6 months• to achieve binocular vision in primary
and downgaze position• most frequent is recession MR or IR
(6-7mm), no more than 3 muscle
![Page 23: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/23.jpg)
Eyelid retractor retraction
• after orbital decompression done• indication:
– ocular discomfort– keratitis, including corneal ulceration, – globe subluxation,– cosmesis
![Page 24: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/24.jpg)
Message home
– Eyelid retraction is the most common feature of TED
– TED is the most common uni/bilateral proptosis, markedly asymmetric
– 90% hyper, but 6% euthyroid– Severity is not parallel to serum level (TSH,
T3, T4..), but the smoking indeed 7x– Urgent care may be require for COM,
severe proptosis cornea decompensat– Surgery should be in order: Orbital
decompression Strabismus eyelid correction
![Page 25: Thyroide Eye Disease](https://reader034.fdocuments.in/reader034/viewer/2022051609/547e5e3ab379596a2b8b546f/html5/thumbnails/25.jpg)
Thank you!!